AQuAS launches two preliminary market consultations to identify AI-based solutions that improve public health

Guia d’avaluació de tecnologies de salut digital que incorporen intel·ligència artificial

The aim of the consultations is to identify available or potential AI solutions that improve adherence to pharmacological treatments and support the diagnosis and monitoring/secondary prevention of stroke.

Share
Share
28 MARCH 2025

Within the framework of the Health/AI Program, AQuAS has opened two preliminary market consultations to identify solutions based on Artificial Intelligence. The first to improve adherence to pharmacological treatments. The second to provide support for the diagnosis and monitoring/secondary prevention of stroke.

The purpose of the procedures is to know the current or potential availability of options and collect information to define the future procedure of each tender, guaranteeing the participation of the maximum number of interested entities.

Entities interested in participating must read the rules and complete the questionnaires for each of the preliminary market consultations.

Improving therapeutic adherence

The consultation is open to digital solutions marketed for improving therapeutic adherence. This includes digital assistants and advanced analytics tools for estimation, risk characterization and prediction of non-adherence. Also digital solutions that empower patients to control their health and optimize medication management and, finally, commercial solutions that allow predicting the risk of clinical events of interest related to medication optimization.

How to participate

From Monday 17th to 31st March 2025 (inclusive), entities interested in participating must complete the online questionnaire which will allow the availability of solutions to address the needs raised to be assessed, as well as their maturity and viability to be adopted. Companies that have responded to the questionnaire may request an optional 30-minute virtual meeting on April 2, 3 and 4 to present their proposal to the project team (AQuAS, Fundació TIC Salut Social, Consorci de Salut i Social de Catalunya and Servei Català de la Salut).

All information is available at Public Procurement Services Platform of the Generalitat of Catalonia (PSCP).

For any questions, you can contact AQuAS by email. contractes.aquas@gencat.cat, indicating in the subject “Challenge AI adherence to pharmacological treatments”.

Diagnosis and secondary prevention of stroke

This consultation seeks to identify innovative solutions based on Artificial Intelligence for the diagnosis and monitoring/secondary prevention of stroke. The proposal must be able to support professionals from the centers of the Stroke Code Reference Network of Catalonia in the interpretation of images, in order to facilitate the process of diagnosis and triage of patients with stroke in the acute phase. It is also expected to help Primary and Community Care (PCC) professionals in the approach to the strategy of secondary prevention and control of vascular risk factors, based on the optimization of etiological diagnosis in the acute phase.

How to participate

From Friday 22nd to 31st March 2025 (inclusive), individuals or entities interested in participating they must fill in the online questionnaire that will allow us to assess the availability of solutions to address the needs raised, as well as their maturity and viability to be adopted.

All information is available at Public Procurement Services Platform of the Generalitat of Catalonia (PSCP).

For any questions, you can contact AQuAS at the following email address: contractes.aquas@gencat.cat, indicating in the subject “IA Stroke Challenge”.